Turquoise Health Targets Healthcare Pricing Chaos with $40M Round
Turquoise Health, a US-based healthtech startup focused on simplifying hospital and insurer prices, has raised $40 million in fresh funding led by a16z and Oak HC/FT. The company aims to become the de facto operating system for the fragmented world of healthcare pricing, where hospitals, insurers and patients struggle to navigate opaque and inconsistent costs.
Building an Operating System for Price Transparency
Since new federal price transparency rules began forcing hospitals and insurers to publish negotiated rates, the market has been flooded with complex, poorly structured data. Turquoise Health aggregates, cleans and normalizes this information into a single platform that can be used by providers, payers, digital health startups and large employers.
The company’s platform uses advanced data standardization and pricing analytics to turn raw machine-readable files into actionable intelligence. By offering APIs and workflow tools, Turquoise Health wants to power everything from contract negotiations and network design to patient-facing price estimates and revenue forecasting.
Backers See Infrastructure Play in Healthcare Data
Investors including a16z and Oak HC/FT view the startup as critical infrastructure for a system under pressure to justify costs. As employers demand more predictable benefits spending and regulators tighten enforcement of transparency rules, demand for reliable pricing data infrastructure is surging.
The new capital will be used to expand engineering and data operations, deepen coverage across hospitals and health plans, and build additional tools for revenue cycle teams, actuaries and benefits leaders. By positioning itself as an “OS” for pricing, Turquoise Health is betting that any organization touching US healthcare payments will eventually need a unified source of truth.
Implications for Patients and the Healthcare Market
If successful, the platform could help drive more competitive healthcare markets, reduce surprise bills and enable more transparent plan design. For patients, that could mean clearer upfront estimates and more informed choices about where to receive care. For the broader industry, it signals a shift toward treating pricing data as a shared, standardized utility rather than a guarded competitive secret.